Bitcoin dropped below $80,000, trading around $79,800 after falling as low as $78,720, with $117 million in 24-hour liquidations mostly from long positions. Rising US inflation and geopolitical tensions following the Trump-Xi meeting caused volatility in Asian markets and pressured cryptocurrencies. The market shows risk-off sentiment with declining open interest and a retreat in altcoin performance, while traders watch $78,000 as key support. This suggests cautious investor behavior amid uncertain global economic and political conditions.
The oligonucleotide drug development pipeline is rapidly expanding, featuring over 600 candidates from more than 200 companies including Novartis, Amgen, and Alnylam. These therapies target genetic diseases, cancers, and rare disorders using advanced...
The global cervical cancer diagnostics market is projected to grow at a compound annual growth rate (CAGR) of about 5% from 2026 to 2034, expanding from $4.4 billion in 2025 to $7.1 billion by 2034. This growth is fueled by rising cervical cancer pre...
AT&T, Verizon, and T-Mobile have agreed to collaborate by pooling spectrum resources and investing jointly in satellite-enabled direct-to-device technology to reduce wireless dead zones, especially in rural and underserved areas. This partnership aim...
Keycard announced Keycard for Multi-Agent Apps, a platform enabling secure, delegated, session-based access for autonomous AI agents. This system allows each AI agent to have its own verifiable identity and limits access strictly to the task at hand,...
Impact Therapeutics, a biotech company specializing in precision cancer drugs, saw its shares double on the first day of trading in Hong Kong after an IPO that was oversubscribed over 2000 times. The company’s lead product, senaparib, is a PARP inhib...
